Edition:
United Kingdom

Innoviva Inc (INVA.OQ)

INVA.OQ on NASDAQ Stock Exchange Global Select Market

19.67USD
18 Jan 2019
Change (% chg)

$0.20 (+1.03%)
Prev Close
$19.47
Open
$19.54
Day's High
$19.81
Day's Low
$19.48
Volume
186,902
Avg. Vol
293,527
52-wk High
$19.81
52-wk Low
$13.27

Chart for

About

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium... (more)

Overall

Beta: 2.58
Market Cap(Mil.): $1,566.05
Shares Outstanding(Mil.): 109.36
Dividend: --
Yield (%): --

Financials

  INVA.OQ Industry Sector
P/E (TTM): 20.00 30.48 33.71
EPS (TTM): 0.72 -- --
ROI: 26.11 14.98 14.48
ROE: -- 16.31 15.99

Earnings vs. Estimates